APIM050057: PCI-27483
CAS No.: 871266-63-6.
Purity: 99.5% (HPLC at 254 nm).
QC: HPLC, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050267: PCI-27483
CAS No.: 871266-63-6.
Purity: 99.5% (HPLC at 254 nm).
QC: HPLC, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.BP002913-PRO-1028: Recombinant Human Phosducin-like protein 3 (PDCL3) Protein
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.C017: ReFacto Biosimilar Stable Cell Line (CHO)
The yield of ReFacto biosimilar from the CHO stable cell line was above 60 IU/mL in a 50 liter manufacturing.
C017: ReFacto Biosimilar Stable Cell Line (CHO)
The yield of ReFacto biosimilar from the CHO stable cell line was above 60 IU/mL in a 50 liter manufacturing.
Biologics production stable cell line development services utilize advanced technology platforms to generate cell lines expressing the target gene at very high levels for the manufacturing of recombinant proteins and antibodies.
- Performed under GLP; manufactured product may be used in FDA Nonclinical Laboratory Studies.
- Parental cell line is cGMP banked with certification.
- Set licensing fee arrangement for commercial production license.
- Cell lineage history of the cell line and testing details facilitate IND filing.BP001901-C479: Recombinant Human Tissue Factor (TF) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001901-PRO-312: Recombinant Human Tissue Factor (TF) Protein
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.PA000265-PA1248: TFPI2 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IH(P);
Reactivity: Human;
Isotype: Rabbit IgG.BP002223-PRO-860: Recombinant Human Tissue Factor Pathway Inhibitor 2 (TFPI2) protein
Source: Nicotiana benthamiana-derived.
Purity: > 97.0% as determined by SDS-PAGE.